Debt-to-equity in % of ATOSSA THERAPEUTICS, INC. from Q3 2015 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ATOSSA THERAPEUTICS, INC. quarterly Debt-to-equity history and change rate from Q3 2015 to Q3 2025.
  • ATOSSA THERAPEUTICS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 10.4 %, a 56.1% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ATOSSA THERAPEUTICS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 10.4 +3.74 +56.1% 30 Sep 2025
Q2 2025 8.58 +3.03 +54.6% 30 Jun 2025
Q1 2025 7.53 +2.93 +63.7% 31 Mar 2025
Q4 2024 7 +3.3 +89% 31 Dec 2024
Q3 2024 6.67 +3.12 +87.8% 30 Sep 2024
Q2 2024 5.55 +2.32 +71.8% 30 Jun 2024
Q1 2024 4.6 +1.48 +47.3% 31 Mar 2024
Q4 2023 3.71 +0.84 +29.3% 31 Dec 2023
Q3 2023 3.55 +1.26 +54.9% 30 Sep 2023
Q2 2023 3.23 +1.23 +61.4% 30 Jun 2023
Q1 2023 3.13 31 Mar 2023
Q4 2022 2.87 31 Dec 2022
Q3 2022 2.3 30 Sep 2022
Q2 2022 2 30 Jun 2022
Q4 2020 35.5 +27.1 +321% 31 Dec 2020
Q3 2020 13.4 +1.72 +14.8% 30 Sep 2020
Q2 2020 11.9 30 Jun 2020
Q1 2020 8.63 31 Mar 2020
Q4 2019 8.43 31 Dec 2019
Q3 2019 11.6 30 Sep 2019
Q4 2015 35.2 31 Dec 2015
Q3 2015 29.8 30 Sep 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.